Professor David Taube has been announced as Director of Imperial College Academic Science Health Centre.

David Taube is one of the country’s leading nephrologists, currently working as medical director at Imperial College Healthcare NHS Trust, and the UK’s only Professor of Transplant Medicine, at Imperial College London.  He will take up the new role on 1 September 2012.

The Imperial College AHSC was established between Imperial College Healthcare NHS Trust and Imperial College London in 2007, the first AHSC to be formed in the UK. The purpose of the AHSC is to use excellence in research and education to transform health outcomes and support the UK’s global position in healthcare by increasing societal and economic gain.

Bringing more than 25 years’ experience in research, education and clinical leadership to the role, Professor Taube, will play a pivotal role in leading the AHSC and realising fully its aspiration to transform healthcare by translating research discoveries into medical advances in as fast a timeframe as is possible.

Reporting jointly to the Principal of the College’s Faculty of Medicine and the Chief Executive of the Trust, he will facilitate close collaboration between the partners. In leading the AHSC, strengthening the interface between clinical and academic activities, he will build on the innovation culture and implement strategies for channelling research excellence to deliver world class healthcare to local, national and global populations.

Welcoming the new appointment, Mark Davies, chief executive of Imperial College Healthcare NHS Trust, said: “I am delighted that Professor Taube has been appointed to lead the AHSC in its next stage of development. He embodies its tripartite mission as he is one of the country’s finest nephrologists, a prolific translational researcher with a proven track record of raising education and training standards and driving the adoption of innovative practice in the largest renal and transplant centre in the UK.”

Sir Keith O’Nions, President & Rector of Imperial College London, said: “We are fortunate that Professor Taube – a national leader in renal medicine – will steer Imperial’s AHSC, harnessing the expertise of the Trust and College to bring benefits to patients. With a highly distinguished reputation as an academic, a clinician and an educator, and as a pioneer of techniques that deliver innovative care to patients, he is well equipped to develop the intersecting activities of the Trust and College. Under his leadership the AHSC will take confident steps forward, making a profound impact on healthcare at a local level and beyond.”

Professor David Taube said: “This is a fantastic opportunity to strengthen the collaboration not simply between the Trust and the College but also between the AHSC and a wider network of partners within the UK and abroad all with the single overarching aim of vastly improving healthcare.

“Improving the care of patients has always driven everything I do and I am hugely excited by the prospect of achieving this through the AHSC in a more sophisticated way and on a much bigger and broader scale.”